Dr. Jessica Rose, an independent researcher in computational biology and immunology, testified before the Allison Inquiry regarding COVID-19 vaccine safety data (0:00 - 1:20). Her testimony focuses on the following key points:

Analysis of Pharmacovigilance Data: Dr. Rose presented data from the U.S. VAERS and V-SAFE systems, arguing that there is a significant, anomalous increase in adverse event reports linked to COVID-19 vaccinations compared to historical baselines (2:10 - 4:40, 27:17 - 31:13).

She suggests that passive reporting systems like VAERS are highly underreported, potentially by a factor of 30 (3:18 - 3:39, 19:14 - 20:52).
Causality Concerns: She emphasized the importance of temporality—the timing between vaccination and the onset of symptoms—as a mandatory criteria for causality (6:24 - 6:47).

She highlighted a high proportion of serious adverse events, including death, occurring shortly after vaccination, which she describes as a clear safety signal that warrants further investigation (34:48 - 37:17).

Critique of Compensation Programs: Dr. Rose raised concerns about both the U.S. and Canadian vaccine injury compensation programs. She criticized the high rejection rates for claims and highlighted the lack of transparency, including the redaction of documents regarding the Canadian program's development and potential conflicts of interest (9:19 - 10:06, 12:13 - 13:25, 15:44 - 16:19).

Recommendations: She advocated for the implementation of mandatory, accessible, and transparent online reporting systems for adverse events to ensure early warning signals are detected (43:08 - 44:52). She also urged a move away from models that underestimate vaccine-related injuries and called for rigorous causality assessments (37:19 - 39:46).